5701 - 5710 of 8654 Results
Title
Year
-
OPENTitle: Use of Figurative Language by People With Parkinson Disease to Describe “Off” PeriodsJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/cpj.0000000000001059Best OA location URL: https://cp.neurology.org/content/neurclinpract/11/4/e462.full.pdfCitation Count: 6
- Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on Aging2019OPENTitle: Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on AgingJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 42Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsz114Best OA location URL: https://academic.oup.com/sleep/article-pdf/42/8/zsz114/29106505/zsz114.pdfCitation Count: 62
- Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination2022OPENTitle: Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examinationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00360-5Best OA location URL: https://www.nature.com/articles/s41531-022-00360-5.pdfCitation Count: 4
- Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease2020OPENTitle: Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00324Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00324/pdfCitation Count: 7
- The experience of off periods: Qualitative analysis of interviews with persons with Parkinson's and carepartners2019OPENTitle: The experience of off periods: Qualitative analysis of interviews with persons with Parkinson's and carepartnersJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 31End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.008Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.008Citation Count: 10
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 14
-
RESTRICTEDTitle: Conquering Neurologic Diseases in Primary CareJournal Name: Primary Care: Clinics in Office PracticePublisher: Elsevier BVVol: 51Issue #: 2Start Page: xvEnd Page: xviPublication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pop.2024.03.001Citation Count: 0
- Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity2022OPENTitle: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00388-7Best OA location URL: https://www.nature.com/articles/s41531-022-00388-7.pdfCitation Count: 43
-
OPENTitle: Analysis of PTRHD1 common and rare variants in European patients with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 107Issue #:Start Page: 178End Page: 180Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.06.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9662088Citation Count: 3
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4